Stock Research for PTCT


Featured Broker: Ally Invest

Get the due diligence for another stock.


PTCT Stock Chart & Research Data

The PTCT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTCT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PTCT Due diligence Resources & Stock Charts

The PTCT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PTCT Detailed Price Forecast - CNN Money CNN View PTCT Detailed Summary - Google Finance
Yahoo View PTCT Detailed Summary - Yahoo! Finance Zacks View PTCT Stock Research & Analysis -

Stock Analysis

TradeIdeas View PTCT Trends & Analysis - Trade-Ideas Barrons View PTCT Major Holders - Barrons
NASDAQ View PTCT Call Transcripts - NASDAQ Seeking View PTCT Breaking News & Analysis - Seeking Alpha
Spotlight View PTCT Annual Report - OTC Report View PTCT OTC Short Report -
TradeKing View PTCT Fundamentals - TradeKing Charts View PTCT SEC Filings - Bar Chart
WSJ View Historical Prices for PTCT - The WSJ Morningstar View Performance/Total Return for PTCT - Morningstar
MarketWatch View the Analyst Estimates for PTCT - MarketWatch CNBC View the Earnings History for PTCT - CNBC
StockMarketWatch View the PTCT Earnings - StockMarketWatch MacroAxis View PTCT Buy or Sell Recommendations - MacroAxis
Bullish View the PTCT Bullish Patterns - American Bulls Short Pains View PTCT Short Pain Metrics -

Social Media Mentions

StockTwits View PTCT Stock Mentions - StockTwits PennyStocks View PTCT Stock Mentions - PennyStockTweets
Twitter View PTCT Stock Mentions - Twitter Invest Hub View PTCT Investment Forum News - Investor Hub
Yahoo View PTCT Stock Mentions - Yahoo! Message Board Seeking Alpha View PTCT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PTCT - Insider Cow View Insider Transactions for PTCT - Insider Cow
CNBC View PTCT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PTCT - OTC Markets
Yahoo View Insider Transactions for PTCT - Yahoo! Finance NASDAQ View Institutional Holdings for PTCT - NASDAQ

Stock Charts

FinViz View PTCT Stock Insight & Charts - StockCharts View PTCT Investment Charts -
BarChart View PTCT Stock Overview & Charts - BarChart Trading View View PTCT User Generated Charts - Trading View

Latest Financial News for PTCT

Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference
Posted on Saturday June 16, 2018

SOUTH PLAINFIELD, N.J., June 16, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) today announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study investigating risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy (SMA), at the 22nd Annual SMA Researcher Meeting. The CHOP-INTEND data were further supported by video footage presented by Dr Baranello demonstrating antigravity movements, the ability to control their head, roll, or sit in babies participating in FIREFISH.  Part 2 of the pivotal FIREFISH study is ongoing. The SMA program is a collaboration between PTC, Roche, and the SMA Foundation.

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Friday June 08, 2018

SOUTH PLAINFIELD, N.J., June 8, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) today announced that on June 7, 2018 it approved non-statutory stock options to purchase an aggregate of 134,450 shares of its common stock to 18 new employees and a restricted stock unit for 3,000 shares of its common stock to one of the new employees.  The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires' employment compensation. The inducement grants were approved by PTC's Compensation Committee on June 7, 2018 and are being made as an inducement material to each employee's acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). Fifteen of the stock option awards have an exercise price of $36.38 per share, the closing price of PTC's common stock on June 7, 2018, the date of the grant.

Edited Transcript of PTCT earnings conference call or presentation 9-May-18 8:30pm GMT
Posted on Thursday June 07, 2018

Q1 2018 PTC Therapeutics Inc Earnings Call

Initiating Free Research Reports on Pulmatrix and Three Other Biotech Equities
Posted on Monday June 04, 2018

Gains were broad based as eight out of nine sectors finished the trading session in green. has initiated research reports on the following Biotechnology stocks: Proteostasis Therapeutics Inc. (NASDAQ: PTI), Prothena Corp. PLC (NASDAQ: PRTA), PTC Therapeutics Inc. (NASDAQ: PTCT), and Pulmatrix Inc. (NASDAQ: PULM).

Enter a stock symbol to view the stock details.